<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-144055" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Cycloplegic and Noncycloplegic Refraction</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kaur</surname>
            <given-names>Kirandeep</given-names>
          </name>
          <aff>Aravind Eye Hospital, Pondicherry</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gurnani</surname>
            <given-names>Bharat</given-names>
          </name>
          <aff>Gomabai Netralaya and Research Centre</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kirandeep Kaur declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Bharat Gurnani declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>11</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-144055.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>The most common cause of visual disability worldwide is refractive errors, and their prompt diagnosis and timely treatment are essential in preventing irreversible visual sequelae, such as amblyopia. Refraction can be divided into cycloplegic and non-cycloplegic. Cycloplegic refraction is the gold standard investigation in children and adults with active accommodation as it paralyzes ciliary muscle and prevents over minus correction because of the accommodative component. The disadvantage can be time-consuming, costly, patient discomfort because of dilatation, and the need for an optometrist to perform a retinoscopy. Non-cycloplegic refraction includes retinoscopy, auto-refraction, and objective and subjective refraction, which are less time-consuming and more comfortable for the patient. Non-cycloplegic refraction is very helpful in vision screening in large volume centers and research settings. This activity highlights the clinical significance of non-cycloplegic and cycloplegic refraction for utility by an interprofessional team.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the difference between cycloplegic and non-cycloplegic refraction.</p></list-item><list-item><p>Review the clinical significance of non-cycloplegic and cycloplegic refraction.</p></list-item><list-item><p>Identify the issue of concern with cycloplegic and non-cycloplegic refraction.</p></list-item><list-item><p>Summarize the procedure of cycloplegic and non-cycloplegic refraction.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=144055&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=144055">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-144055.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Refractive errors are an important common cause of visual disturbance worldwide.<xref ref-type="bibr" rid="article-144055.r1">[1]</xref> The prevalence of types and degree of refractive errors may vary from region to region.<xref ref-type="bibr" rid="article-144055.r2">[2]</xref> Vitale et al., in their analysis of the United States, found astigmatism as the most common refractive error with a prevalence of 36.2%, followed by myopia with a prevalence of 33.1%, and least being hyperopia with a prevalence of 3.6%.<xref ref-type="bibr" rid="article-144055.r3">[3]</xref>&#x000a0;</p>
        <p>Further, myopia was more prevalent in females (39.9%) than males (32.6%). Sethu et al. found the prevalence of refractive error of at least 0.50 diopter (D) spherical, equivalent to 53.1%. Myopia and hypermetropia were found to be the most common refractive errors accounting for 27.7% and 22.9%, respectively.<xref ref-type="bibr" rid="article-144055.r4">[4]</xref>&#x000a0;</p>
        <p>Symptoms related to refractive errors are quite disturbing and may even disrupt the normal lifestyle of individuals. Refractive error patients form the majority of outpatient patients visiting an optometrist or ophthalmology clinic. A study by Schiefer et al. found refractive errors accounted for 21.1% of the patients presenting to an ophthalmologist.<xref ref-type="bibr" rid="article-144055.r5">[5]</xref></p>
        <p>The evaluation of these patients can be occasionally aided by topical agents called cycloplegic drugs.<xref ref-type="bibr" rid="article-144055.r6">[6]</xref> Thus refraction can be broadly divided into cycloplegic and non-cycloplegic refraction. Cycloplegic drugs are often used to evaluate patients for underlying refractive errors. Cycloplegics cause temporary paralysis of ciliary muscles allowing the determination of total refractive errors.<xref ref-type="bibr" rid="article-144055.r7">[7]</xref> Cycloplegic retinoscopy is also known as wet retinoscopy. Cycloplegics have been used since the 19 century to assess refractive errors by relaxing the accommodation.<xref ref-type="bibr" rid="article-144055.r8">[8]</xref> &#x000a0;</p>
        <p>Noncycloplegic refraction is performed without any drug administration. It doesn't affect the accommodation and pupil dilatation.<xref ref-type="bibr" rid="article-144055.r9">[9]</xref> The various listed methods of non-cycloplegic refraction are retinoscopy, autorefraction, and objective and subjective refraction. A detailed description of how to perform retinoscopy and refraction is beyond the scope of this chapter and is discussed in separate chapters.</p>
        <p>&#x000a0;<bold>Difference between Cycloplegic and Noncycloplegic Refraction</bold></p>
        <table-wrap id="article-144055.table0" position="float" orientation="portrait">
          <table>
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>S. No </bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Characteristic</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Cycloplegic</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Noncycloplegic</bold></p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>1</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p>Pupil dilatation</p>
</td>
                <td rowspan="1" colspan="1">
<p>Dilated</p>
</td>
                <td rowspan="1" colspan="1">
<p>Undilated</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>2</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p>Accommodation</p>
</td>
                <td rowspan="1" colspan="1">
<p>Lost</p>
</td>
                <td rowspan="1" colspan="1">
<p>Intact</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>3</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p>Time</p>
</td>
                <td rowspan="1" colspan="1">
<p>Need more time</p>
</td>
                <td rowspan="1" colspan="1">
<p>Need less time</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>4</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p>Drugs</p>
</td>
                <td rowspan="1" colspan="1">
<p>Atropine, Cyclopentolate, Tropicamide,&#x000a0; Homatropine</p>
</td>
                <td rowspan="1" colspan="1">
<p>Not needed</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>5</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p>Types</p>
</td>
                <td rowspan="1" colspan="1">
<p>-</p>
</td>
                <td rowspan="1" colspan="1">
<p>Retinoscopy, Autorefractor, Objective and Subjective retinoscopy</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>6</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p>Cost</p>
</td>
                <td rowspan="1" colspan="1">
<p>Costly</p>
</td>
                <td rowspan="1" colspan="1">
<p>Less costly</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>7</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p>Patient convenience</p>
</td>
                <td rowspan="1" colspan="1">
<p>Less</p>
</td>
                <td rowspan="1" colspan="1">
<p>More</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="article-144055.s3" sec-type="Function">
        <title>Function</title>
        <p>Cycloplegics are drugs that paralyze the ciliary muscles and cause relaxation of accommodation. Once the ciliary muscles are relaxed, the anterior zonules stretch, and posterior zonules lose tension leading to thinning of the lens. This allows the eye to be relaxed and helps in focusing on distance.<xref ref-type="bibr" rid="article-144055.r10">[10]</xref></p>
        <p>Cycloplegic drugs are the anticholinergic agents that block acetylcholine's muscarinic action in ciliary muscle receptors. This inhibits the cholinergic stimulation of the iris sphincter and ciliary muscles, allowing relaxation of accommodation and inhibiting the accommodative power of the eye.<xref ref-type="bibr" rid="article-144055.r11">[11]</xref></p>
        <p>The various cycloplegic agents are atropine sulfate, homatropine hydrobromide, cyclopentolate hydrochloride, and tropicamide.</p>
        <p>
<bold>Atropine Sulphate </bold>
</p>
        <p>It is an anticholinergic agent that acts directly on muscarinic receptors of structure innervated by post-ganglionic parasympathetic fibers. It is available in 0.01%, 0.5%, 1% and 3% topical ophthalmic drops and ointment. For refraction, 1% atropine ointment should be applied as a morning dose for three days. Atropine is one of the strongest drugs available for cycloplegia. It paralyzes the sphincter pupillae and ciliary muscles, thus causing mydriasis and cycloplegia. Atropine is a competitive inhibitor of the muscarinic action of acetylcholine.<xref ref-type="bibr" rid="article-144055.r12">[12]</xref></p>
        <p>Apart from its use as a cycloplegic agent, atropine is also indicated for pupillary dilatation in inflammatory conditions to prevent pain and release synechiae. It is also used in ciliary block glaucoma, for penalization as part of amblyopia management, to treat accommodation spasms, to prevent undue vagal response in Tensilon test, and pre and post-operatively in some intraocular surgeries. Low dose atropine in the form of 0.01% topical application is widely accepted to control myopia progression. Atropine is contraindicated in patients with primary angle glaucoma or narrow anterior chambers. It is also contraindicated among those with hypersensitivity to any preparation components.<xref ref-type="bibr" rid="article-144055.r8">[8]</xref></p>
        <p>
<bold>Homatropine Hydrobromide</bold>
</p>
        <p>It is an anticholinergic agent used as a 2% sterile ophthalmic solution. It acts in the same manner as atropine by blocking the muscarinic action of acetylcholine, thus causing mydriasis and cycloplegia. It is also used for penalization therapy in amblyopia and to treat ocular inflammatory conditions like iritis. This is used as one drop repeated every 10 minutes six times for performing cycloplegic refraction. Retinoscopy can be performed after about 90 minutes of installing the first drop. The effect lasts for 48&#x000a0;to 72 hours. A drug correction of 0.5D is done from the retinoscopy value as tonus allowance.<xref ref-type="bibr" rid="article-144055.r12">[12]</xref></p>
        <p>
<bold>Cyclopentolate Hydrochloride</bold>
</p>
        <p>It is also an anti-cholinergic agent used as a 1% sterile ophthalmic solution as a cycloplegic action. It is also available as 0.5% and 2% formulations. Cyclopentolate has a faster onset of action and a shorter duration of effect. Cycloplegia action occurs in 30&#x000a0;to 45 minutes of instillation. It is applied as one drop and repeated after 5 minutes. The effect of the drug lasts 6&#x000a0;to 18 hours. A drug correction of 0.75D is done from the retinoscopy value as tonus allowance.<xref ref-type="bibr" rid="article-144055.r8">[8]</xref></p>
        <p>
<bold>Tropicamide</bold>
</p>
        <p>This is a commonly used anti-cholinergic mydriatic drug. The drug has a powerful mydriatic effect, fast onset of action, and low side effect profile. Tropicamide is available at a dose of 0.5% and 1%. It works by blocking the muscarinic acetylcholine receptors. The 1 % preparation paralyzes the accommodation. The 0.5% strength produces mydriasis with slight cycloplegia. Tropicamide is implicated in mydriasis and cycloplegia, diagnosis, and short-acting mydriatic for pre and post-operative stages. The pupillary dilatation is less dependent on iris pigmentation. For premature infants combination of 2.5% phenylephrine and 5% is recommended due to less dilatation alone.<xref ref-type="bibr" rid="article-144055.r13">[13]</xref></p>
        <p>
<bold>Characteristic Features of Cycloplegics and Mydriatics</bold>
<bold>&#x000a0;</bold>
</p>
        <table-wrap id="article-144055.table1" position="float" orientation="portrait">
          <table>
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>S. No</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Drug</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>&#x000a0;Age Group</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Dose</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Peak effect</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Timing of Retinoscopy</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Duration of action</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Cycloplegic effect</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Tonus allowance</bold></p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>1</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p>Atropine</p>
<p>Sulfate (1% ointment)</p>
</td>
                <td rowspan="1" colspan="1">
<p>Below 5 years</p>
</td>
                <td rowspan="1" colspan="1">
<p>Three times x 3 days</p>
</td>
                <td rowspan="1" colspan="1">
<p>2-3 days</p>
</td>
                <td rowspan="1" colspan="1">
<p>4 day</p>
</td>
                <td rowspan="1" colspan="1">
<p>10-20 days</p>
</td>
                <td rowspan="1" colspan="1">
<p>After 3 weeks of retinoscopy</p>
</td>
                <td rowspan="1" colspan="1">
<p>1 D</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>2</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p>Homatropine</p>
<p>hydrobromide</p>
<p>(2% drops)</p>
</td>
                <td rowspan="1" colspan="1">
<p>5-8 years</p>
</td>
                <td rowspan="1" colspan="1">
<p>One drop for every 10 mins ( 6 times)</p>
</td>
                <td rowspan="1" colspan="1">
<p>1-1.5 hours</p>
</td>
                <td rowspan="1" colspan="1">
<p>After 90 minutes of drug administration</p>
</td>
                <td rowspan="1" colspan="1">
<p>2-3 days</p>
</td>
                <td rowspan="1" colspan="1">
<p>After 3 weeks of retinoscopy</p>
</td>
                <td rowspan="1" colspan="1">
<p>0.5 D</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>3</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p>Cyclopentolate hydrochloride (1% drops)</p>
</td>
                <td rowspan="1" colspan="1">
<p>8-20 years</p>
</td>
                <td rowspan="1" colspan="1">
<p>One drop every 15 mins (3 times)</p>
</td>
                <td rowspan="1" colspan="1">
<p>80-90 minutes</p>
</td>
                <td rowspan="1" colspan="1">
<p>After 90 minutes of drug administration</p>
<p>(Havener's recommended dose)</p>
</td>
                <td rowspan="1" colspan="1">
<p>6-18 hours</p>
</td>
                <td rowspan="1" colspan="1">
<p>After 3 days of retinoscopy</p>
</td>
                <td rowspan="1" colspan="1">
<p>0.75 D</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>4</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p>Tropicamide (0.5%, 1% drops)</p>
</td>
                <td rowspan="1" colspan="1">
<p>Above 15 years, used as a mydriatic</p>
</td>
                <td rowspan="1" colspan="1">
<p>One drop every 15 mins (3-4 times)</p>
</td>
                <td rowspan="1" colspan="1">
<p>20-40 minutes</p>
</td>
                <td rowspan="1" colspan="1">
<p>-</p>
</td>
                <td rowspan="1" colspan="1">
<p>4-6 hours</p>
</td>
                <td rowspan="1" colspan="1">
<p>-</p>
</td>
                <td rowspan="1" colspan="1">
<p>-</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="article-144055.s4" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>Cycloplegics are contraindicated in patients with the shallow anterior chamber, close angle-closure glaucoma, history of allergy or hypersensitivity to any component of drugs, and systemic anticholinergic drugs receiver.<xref ref-type="bibr" rid="article-144055.r14">[14]</xref></p>
        <p>Atropine gets absorbed systemically through the lacrimal sac and thus should be avoided in children as far as possible.<xref ref-type="bibr" rid="article-144055.r15">[15]</xref></p>
        <p>It is advisable to compress the lacrimal sac for a minute after topical application to prevent systemic absorption. Though uncommon, few local side effects reported with atropine include the allergic reaction of lids and conjunctiva, crusting of lid margins, and dryness of periocular skin.<xref ref-type="bibr" rid="article-144055.r15">[15]</xref>&#x000a0;</p>
        <p>The blurring of vision and photophobia are direct consequences of cycloplegic and mydriatic effects of atropine. Systemic side effects include dryness of skin and mouth, tachycardia, irritability, delirium, flushing, skin rashes, abdominal distension, or hyperpyrexia. Very rarely, a severe reaction in the form of progressive respiratory depression has also been reported.<xref ref-type="bibr" rid="article-144055.r16">[16]</xref></p>
        <p>Homatropine can rarely have side effects, including incoherent speech, hallucinations, disorientation, psychosis, and visual disturbances.<xref ref-type="bibr" rid="article-144055.r17">[17]</xref></p>
        <p>Cyclopentolate is rarely associated with side effects like lacrimation and blurred vision. Systemic side effects include hallucinations, ataxia, disorientation, disturbance in speech, and restlessness.<xref ref-type="bibr" rid="article-144055.r18">[18]</xref></p>
        <p>Tropicamide is contraindicated in angle-closure glaucoma and hypersensitivity to the drug. Tropicamide is linked with CNS disturbance in infants and children. It should be used carefully in the elderly and cases with increased IOP. Tropicamide locally causes a stinging sensation, and systemic absorption may result in confusion and hypersensitivity reaction in children.<xref ref-type="bibr" rid="article-144055.r19">[19]</xref></p>
      </sec>
      <sec id="article-144055.s5" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Cycloplegics are considered the standard of care for certain clinical scenarios like pediatric age group, constant or intermittent esotropia, pseudo myopia, latent hyperopia, accommodation insufficiency, accommodation fatigue, or accommodation spasm. Cycloplegic refraction is also recommended in patients with amblyopia or underlying strabismus.<xref ref-type="bibr" rid="article-144055.r20">[20]</xref></p>
        <p>The American Optometric Association (AOA) guidelines also recommend cycloplegic examination of pre-schoolers for screening ocular conditions like significant refractive errors, anisometropia, strabismus, or amblyopia. The underlying clinical conditions leading to decreased vision can potentially threaten long-term sequelae. Thus, it is essential to evaluate the children at a young age to allow timely diagnoses and treatment.<xref ref-type="bibr" rid="article-144055.r21">[21]</xref></p>
        <p>Retinoscopy is performed in dim room illumination. The patient should be seated at a &#x000a0;distance of 1 meter from the examiner. The retinoscope light is thrown into the patient's eye, and the patient is asked to look at the retinoscopic light. This is in contrast to dry retinoscopy, where the patient is asked to look at a distant point to allow relaxation of accommodation. The red reflex is noted through a hole in the retinoscope mirror in the patient's pupillary area. The retinoscope is moved in the horizontal and vertical meridian while observing the retinoscopic reflex.<xref ref-type="bibr" rid="article-144055.r22">[22]</xref></p>
        <p>The important inferences made from the movement of retinoscopic reflex depend on the distance and mirror used. For the setting of the plane mirror used at 1 meter, the interpretations are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>No movement of red reflex indicates myopia of 1 diopter (D)</p>
          </list-item>
          <list-item>
            <p>The movement of red reflex along the direction of the retinoscope indicates either emmetropia or hypermetropia, or myopia of less than 1 D</p>
          </list-item>
          <list-item>
            <p>The movement of the red reflex against the direction of the retinoscope implies myopia of more than 1 D.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-144055.s6" sec-type="Other Issues">
        <title>Other Issues</title>
        <p>As accommodation is lost due to cycloplegia, the patient will complain of blurred vision, photophobia, and difficulty focusing near objects. The patient must rest for at least 3&#x000a0;to 6 hours until accommodation reverses. This will hamper the routine activities of the patient. Sometimes the cycloplegic refraction of the patient doesn't match with that of subjective refraction or non-cycloplegic refraction. Hence, post mydriatic test should be done in these cases<bold>&#x000a0;</bold>before the final spectacle prescription.<xref ref-type="bibr" rid="article-144055.r23">[23]</xref></p>
      </sec>
      <sec id="article-144055.s7" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Pediatric patients below 13&#x000a0;to 14 years of age presenting with defective vision and having underlying refractive error should be subjected to cycloplegic refraction.<xref ref-type="bibr" rid="article-144055.r24">[24]</xref></p>
        <p>Patients in the age group of 14&#x000a0;to 35 years should be evaluated with tropicamide refraction. After cycloplegic or tropicamide refraction, the final contact lens or glass prescription should be given. All ophthalmologists and optometrists must know the indications and importance of cycloplegic and non-cycloplegic refraction to avoid the progression of refractive error.<xref ref-type="bibr" rid="article-144055.r25">[25]</xref></p>
        <p>The optometrists play a crucial role in explaining and performing non-cycloplegic and cycloplegic refraction. Ophthalmologists play a vital role in treatment, counseling, and explaining the prognosis to the patients.<xref ref-type="bibr" rid="article-144055.r26">[26]</xref></p>
      </sec>
      <sec id="article-144055.s8" sec-type="Nursing, Allied Health, and Interprofessional Team Interventions">
        <title>Nursing, Allied Health, and Interprofessional Team Interventions</title>
        <p>The nursing and the allied staff play a vital role in receiving the patient to the clinic, registering basic ophthalmic complaints, explaining to the patient the methodology and duration of a cycloplegic refraction, the need for cycloplegic refraction, and the side effects of instilling side effects. The nursing team also helps in counseling and procuring spectacle for the patients in cases of refractive error.<xref ref-type="bibr" rid="article-144055.r27">[27]</xref></p>
      </sec>
      <sec id="article-144055.s9" sec-type="Nursing, Allied Health, and Interprofessional Team Monitoring">
        <title>Nursing, Allied Health, and Interprofessional Team Monitoring</title>
        <p>The nursing and the allied staff help monitor the progress of cycloplegic refraction by instilling cycloplegic drugs at regular intervals and assessing the pupillary dilatation. They also help patients' regular and smooth flow in the clinics without prolonged wait time.<xref ref-type="bibr" rid="article-144055.r28">[28]</xref></p>
      </sec>
      <sec id="article-144055.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=144055&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=144055">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/144055/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=144055">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-144055.s11">
        <fig id="article-144055.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Digital image of the patient depicting visual acuity evaluation before performing a cycloplegic refraction in a young male. Contributed by Dr. Kirandeep Kaur, MBBS, DNB, FPOS, FICO, MRCS Ed, MNAMS</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-144055.s12">
        <title>References</title>
        <ref id="article-144055.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gomez-Salazar</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Campos-Romero</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gomez-Campa&#x000f1;a</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Cruz-Zamudio</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chaidez-Felix</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Leon-Sicairos</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Velazquez-Roman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Flores-Villase&#x000f1;or</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Muro-Amador</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Guadron-Llanos</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Martinez-Garcia</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Murillo-Llanes</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sanchez-Cuen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Llausas-Vargas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Alapizco-Castro</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Irineo-Cabrales</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Graue-Hernandez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ramirez-Luquin</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Canizalez-Roman</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Refractive errors among children, adolescents and adults attending eye clinics in Mexico.</article-title>
            <source>Int J Ophthalmol</source>
            <year>2017</year>
            <volume>10</volume>
            <issue>5</issue>
            <fpage>796</fpage>
            <page-range>796-802</page-range>
            <pub-id pub-id-type="pmid">28546940</pub-id>
          </element-citation>
        </ref>
        <ref id="article-144055.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hashemi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fotouhi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yekta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pakzad</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ostadimoghaddam</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Khabazkhoob</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Global and regional estimates of prevalence of refractive errors: Systematic review and meta-analysis.</article-title>
            <source>J Curr Ophthalmol</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>30</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-22</page-range>
            <pub-id pub-id-type="pmid">29564404</pub-id>
          </element-citation>
        </ref>
        <ref id="article-144055.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vitale</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ellwein</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cotch</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Ferris</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Sperduto</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of refractive error in the United States, 1999-2004.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2008</year>
            <month>Aug</month>
            <volume>126</volume>
            <issue>8</issue>
            <fpage>1111</fpage>
            <page-range>1111-9</page-range>
            <pub-id pub-id-type="pmid">18695106</pub-id>
          </element-citation>
        </ref>
        <ref id="article-144055.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sheeladevi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Seelam</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Nukella</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Borah</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Keay</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of refractive errors, uncorrected refractive error, and presbyopia in adults in India: A systematic review.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2019</year>
            <month>May</month>
            <volume>67</volume>
            <issue>5</issue>
            <fpage>583</fpage>
            <page-range>583-592</page-range>
            <pub-id pub-id-type="pmid">31007213</pub-id>
          </element-citation>
        </ref>
        <ref id="article-144055.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schiefer</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Kraus</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Baumbach</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ungewi&#x000df;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Michels</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Refractive errors.</article-title>
            <source>Dtsch Arztebl Int</source>
            <year>2016</year>
            <month>Oct</month>
            <day>14</day>
            <volume>113</volume>
            <issue>41</issue>
            <fpage>693</fpage>
            <page-range>693-702</page-range>
            <pub-id pub-id-type="pmid">27839543</pub-id>
          </element-citation>
        </ref>
        <ref id="article-144055.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sun</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Wei</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>XH</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>CX</given-names>
              </name>
              <name>
                <surname>Du</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Morgan</surname>
                <given-names>IG</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>NL</given-names>
              </name>
            </person-group>
            <article-title>Cycloplegic refraction by 1% cyclopentolate in young adults: is it the gold standard? The Anyang University Students Eye Study (AUSES).</article-title>
            <source>Br J Ophthalmol</source>
            <year>2018</year>
            <month>Jun</month>
            <day>21</day>
            <pub-id pub-id-type="pmid">29930099</pub-id>
          </element-citation>
        </ref>
        <ref id="article-144055.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krantz</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Cruickshanks</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Nieto</surname>
                <given-names>FJ</given-names>
              </name>
            </person-group>
            <article-title>Measuring refraction in adults in epidemiological studies.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>128</volume>
            <issue>1</issue>
            <fpage>88</fpage>
            <page-range>88-92</page-range>
            <pub-id pub-id-type="pmid">20065223</pub-id>
          </element-citation>
        </ref>
        <ref id="article-144055.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sani</surname>
                <given-names>RY</given-names>
              </name>
              <name>
                <surname>Hassan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Habib</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Ifeanyichukwu</surname>
                <given-names>EP</given-names>
              </name>
            </person-group>
            <article-title>Cycloplegic effect of atropine compared with cyclopentolate-tropicamide combination in children with hypermetropia.</article-title>
            <source>Niger Med J</source>
            <year>2016</year>
            <season>May-Jun</season>
            <volume>57</volume>
            <issue>3</issue>
            <fpage>173</fpage>
            <page-range>173-7</page-range>
            <pub-id pub-id-type="pmid">27397958</pub-id>
          </element-citation>
        </ref>
        <ref id="article-144055.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Xie</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hou</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Thorn</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Cycloplegic and noncycloplegic refractions of Chinese neonatal infants.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2011</year>
            <month>Apr</month>
            <day>14</day>
            <volume>52</volume>
            <issue>5</issue>
            <fpage>2456</fpage>
            <page-range>2456-61</page-range>
            <pub-id pub-id-type="pmid">21087952</pub-id>
          </element-citation>
        </ref>
        <ref id="article-144055.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Erickson-Lamy</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Polansky</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Kaufman</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Zlock</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Cholinergic drugs alter ciliary muscle response and receptor content.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>1987</year>
            <month>Feb</month>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>375</fpage>
            <page-range>375-83</page-range>
            <pub-id pub-id-type="pmid">8591921</pub-id>
          </element-citation>
        </ref>
        <ref id="article-144055.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Svoboda</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Popelikova</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Stuchlik</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Drugs Interfering with Muscarinic Acetylcholine Receptors and Their Effects on Place Navigation.</article-title>
            <source>Front Psychiatry</source>
            <year>2017</year>
            <volume>8</volume>
            <fpage>215</fpage>
            <pub-id pub-id-type="pmid">29170645</pub-id>
          </element-citation>
        </ref>
        <ref id="article-144055.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Crom</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Crom</surname>
                <given-names>WR</given-names>
              </name>
            </person-group>
            <article-title>Memo on medications: atropine sulfate and homatropine hydrobromide: common mydriatic/cycloplegic agents.</article-title>
            <source>J Ophthalmic Nurs Technol</source>
            <year>1982</year>
            <month>Aug</month>
            <volume>1</volume>
            <issue>2</issue>
            <fpage>38</fpage>
            <page-range>38-40</page-range>
            <pub-id pub-id-type="pmid">6980991</pub-id>
          </element-citation>
        </ref>
        <ref id="article-144055.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hofmeister</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Kaupp</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Schallhorn</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Comparison of tropicamide and cyclopentolate for cycloplegic refractions in myopic adult refractive surgery patients.</article-title>
            <source>J Cataract Refract Surg</source>
            <year>2005</year>
            <month>Apr</month>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>694</fpage>
            <page-range>694-700</page-range>
            <pub-id pub-id-type="pmid">15899444</pub-id>
          </element-citation>
        </ref>
        <ref id="article-144055.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ah-Kee</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Egong</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Shafi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Yim</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>A review of drug-induced acute angle closure glaucoma for non-ophthalmologists.</article-title>
            <source>Qatar Med J</source>
            <year>2015</year>
            <volume>2015</volume>
            <issue>1</issue>
            <fpage>6</fpage>
            <pub-id pub-id-type="pmid">26535174</pub-id>
          </element-citation>
        </ref>
        <ref id="article-144055.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Farkouh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Frigo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Czejka</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Systemic side effects of eye drops: a pharmacokinetic perspective.</article-title>
            <source>Clin Ophthalmol</source>
            <year>2016</year>
            <volume>10</volume>
            <fpage>2433</fpage>
            <page-range>2433-2441</page-range>
            <pub-id pub-id-type="pmid">27994437</pub-id>
          </element-citation>
        </ref>
        <ref id="article-144055.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rengstorff</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Doughty</surname>
                <given-names>CB</given-names>
              </name>
            </person-group>
            <article-title>Mydriatic and cycloplegic drugs: a review of ocular and systemic complications.</article-title>
            <source>Am J Optom Physiol Opt</source>
            <year>1982</year>
            <month>Feb</month>
            <volume>59</volume>
            <issue>2</issue>
            <fpage>162</fpage>
            <page-range>162-77</page-range>
            <pub-id pub-id-type="pmid">7039329</pub-id>
          </element-citation>
        </ref>
        <ref id="article-144055.r17">
          <label>17</label>
          <element-citation publication-type="book">
            <chapter-title>Homatropine</chapter-title>
            <source>Drugs and Lactation Database (LactMed&#x000ae;) [Internet]</source>
            <publisher-name>National Institute of Child Health and Human Development</publisher-name>
            <publisher-loc>Bethesda (MD)</publisher-loc>
            <year>2021</year>
            <month>4</month>
            <day>19</day>
            <pub-id pub-id-type="pmid">30000723</pub-id>
          </element-citation>
        </ref>
        <ref id="article-144055.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rajeev</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Adhikari</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Yadav</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Sathyamoorthy</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Neurotoxic Effects of Topical Cyclopentolate.</article-title>
            <source>Med J Armed Forces India</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>66</volume>
            <issue>3</issue>
            <fpage>288</fpage>
            <page-range>288-9</page-range>
            <pub-id pub-id-type="pmid">27408323</pub-id>
          </element-citation>
        </ref>
        <ref id="article-144055.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Portney</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Purcell</surname>
                <given-names>TW</given-names>
              </name>
            </person-group>
            <article-title>The influence of tropicamide on intraocular pressure.</article-title>
            <source>Ann Ophthalmol</source>
            <year>1975</year>
            <month>Jan</month>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>31</fpage>
            <page-range>31-4</page-range>
            <pub-id pub-id-type="pmid">1111414</pub-id>
          </element-citation>
        </ref>
        <ref id="article-144055.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wallace</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Morse</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Melia</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sprunger</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Repka</surname>
                <given-names>MX</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Christiansen</surname>
                <given-names>SP</given-names>
              </name>
              <collab>American Academy of Ophthalmology Preferred Practice Pattern Pediatric Ophthalmology/Strabismus Panel</collab>
            </person-group>
            <article-title>Pediatric Eye Evaluations Preferred Practice Pattern&#x000ae;: I. Vision Screening in the Primary Care and Community Setting; II. Comprehensive Ophthalmic Examination.</article-title>
            <source>Ophthalmology</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>125</volume>
            <issue>1</issue>
            <fpage>P184</fpage>
            <page-range>P184-P227</page-range>
            <pub-id pub-id-type="pmid">29108745</pub-id>
          </element-citation>
        </ref>
        <ref id="article-144055.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Major</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Dutson</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Moshirfar</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Cycloplegia in Children: An Optometrist's Perspective.</article-title>
            <source>Clin Optom (Auckl)</source>
            <year>2020</year>
            <volume>12</volume>
            <fpage>129</fpage>
            <page-range>129-133</page-range>
            <pub-id pub-id-type="pmid">32904515</pub-id>
          </element-citation>
        </ref>
        <ref id="article-144055.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cordero</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Understanding and looking after a retinoscope and trial lens set.</article-title>
            <source>Community Eye Health</source>
            <year>2017</year>
            <volume>30</volume>
            <issue>98</issue>
            <fpage>40</fpage>
            <page-range>40-41</page-range>
            <pub-id pub-id-type="pmid">29070929</pub-id>
          </element-citation>
        </ref>
        <ref id="article-144055.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kl&#x000ed;ma</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Juran</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Klimov&#x000e1;</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>[Cycloplegia and residual accommodation (author's transl)].</article-title>
            <source>Klin Monbl Augenheilkd</source>
            <year>1975</year>
            <month>Jul</month>
            <volume>167</volume>
            <issue>1</issue>
            <fpage>106</fpage>
            <page-range>106-10</page-range>
            <pub-id pub-id-type="pmid">1242785</pub-id>
          </element-citation>
        </ref>
        <ref id="article-144055.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saxena</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>P</given-names>
              </name>
              <collab>Pediatric Ophthalmology Expert Group</collab>
            </person-group>
            <article-title>National consensus statement regarding pediatric eye examination, refraction, and amblyopia management.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>68</volume>
            <issue>2</issue>
            <fpage>325</fpage>
            <page-range>325-332</page-range>
            <pub-id pub-id-type="pmid">31957721</pub-id>
          </element-citation>
        </ref>
        <ref id="article-144055.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yazdani</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sadeghi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Momeni-Moghaddam</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zarifmahmoudi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ehsaei</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Comparison of cyclopentolate versus tropicamide cycloplegia: A systematic review and meta-analysis.</article-title>
            <source>J Optom</source>
            <year>2018</year>
            <season>Jul-Sep</season>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>135</fpage>
            <page-range>135-143</page-range>
            <pub-id pub-id-type="pmid">29132914</pub-id>
          </element-citation>
        </ref>
        <ref id="article-144055.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Vasudevan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ciuffreda</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Mao</surname>
                <given-names>GY</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>YB</given-names>
              </name>
            </person-group>
            <article-title>The difference between cycloplegic and non-cycloplegic autorefraction and its association with progression of refractive error in Beijing urban children.</article-title>
            <source>Ophthalmic Physiol Opt</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>37</volume>
            <issue>4</issue>
            <fpage>489</fpage>
            <page-range>489-497</page-range>
            <pub-id pub-id-type="pmid">28503812</pub-id>
          </element-citation>
        </ref>
        <ref id="article-144055.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hadavand</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Heidary</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Heidary</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gharebaghi</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Role of ophthalmic nurses in prevention of ophthalmic diseases.</article-title>
            <source>Med Hypothesis Discov Innov Ophthalmol</source>
            <year>2013</year>
            <season>Winter</season>
            <volume>2</volume>
            <issue>4</issue>
            <fpage>92</fpage>
            <page-range>92-5</page-range>
            <pub-id pub-id-type="pmid">24822227</pub-id>
          </element-citation>
        </ref>
        <ref id="article-144055.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kyei</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nketsiah</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Asiedu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Awuah</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Owusu-Ansah</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Onset and duration of cycloplegic action of 1% cyclopentolate - 1% tropicamide combination.</article-title>
            <source>Afr Health Sci</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>17</volume>
            <issue>3</issue>
            <fpage>923</fpage>
            <page-range>923-932</page-range>
            <pub-id pub-id-type="pmid">29085421</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
